Search filters

A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article
Author/s

author: Diego Cortinovis  Domenico Galetta 

Publication date June 27, 2016
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item